Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies

Daniel Reichart(Brigham and Women's Hospital), Eric L. Lindberg(Max Delbrück Center), Henrike Maatz(Max Delbrück Center), Antonio M. A. Miranda(British Heart Foundation), Anissa Viveiros(University of Alberta), Nikolay Shvetsov(Max Delbrück Center), Anna Gärtner(Heart and Diabetes Center North Rhine-Westphalia), Emily R. Nadelmann(Harvard University), Michael Lee(Imperial College London), Kazumasa Kanemaru(Wellcome Sanger Institute), Jorge Ruiz‐Orera(Max Delbrück Center), Viktoria Strohmenger(Harvard University), Daniel M. DeLaughter(Howard Hughes Medical Institute), Giannino Patone(Max Delbrück Center), Hao Zhang(University of Alberta), Andrew Woehler(Max Delbrück Center), Christoph Lippert(Hasso Plattner Institute), Yuri Kim(Brigham and Women's Hospital), Eleonora Adami(Max Delbrück Center), Joshua Gorham(Harvard University), Sam N. Barnett(Imperial College London), Kemar Brown(Harvard University), Rachel Buchan(Guy's and St Thomas' NHS Foundation Trust), Rasheda A. Chowdhury(Imperial College London), Chrystalla Constantinou(Imperial College London), James Cranley(Wellcome Sanger Institute), Leanne E. Felkin(Guy's and St Thomas' NHS Foundation Trust), Henrik Fox(Heart and Diabetes Center North Rhine-Westphalia), Ahla Ghauri(Max Delbrück Center), Jan Gummert(Heart and Diabetes Center North Rhine-Westphalia), Masatoshi Kanda(Sapporo Medical University), Ruoyan Li(Wellcome Sanger Institute), Lukáš Mach(Guy's and St Thomas' NHS Foundation Trust), Barbara McDonough(Brigham and Women's Hospital), Sara Samari(Imperial College London), Farnoush Shahriaran(Helmholtz Zentrum München), Clarence Yapp(Harvard University), Caroline Stanasiuk(Heart and Diabetes Center North Rhine-Westphalia), Pantazis Theotokis(MRC London Institute of Medical Sciences), Fabian J. Theis(Helmholtz Zentrum München), Antoon van den Bogaerdt(Netherlands Consortium for Healthy Ageing), Hiroko Wakimoto(Harvard University), James S. Ware(Guy's and St Thomas' NHS Foundation Trust), Catherine L. Worth(Max Delbrück Center), Paul J.R. Barton(Guy's and St Thomas' NHS Foundation Trust), Young‐Ae Lee(Max Delbrück Center), Sarah A. Teichmann(University of Cambridge), Hendrik Milting(Heart and Diabetes Center North Rhine-Westphalia), Michela Noseda(British Heart Foundation), Gavin Y. Oudit(University of Alberta), Matthias Heinig(Helmholtz Zentrum München), Jonathan G. Seidman(Harvard University), Norbert Hübner(Max Delbrück Center), Christine E. Seidman(Brigham and Women's Hospital)
Science
August 4, 2022
Cited by 234Open Access
Full Text

Abstract

Pathogenic variants in genes that cause dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM) convey high risks for the development of heart failure through unknown mechanisms. Using single-nucleus RNA sequencing, we characterized the transcriptome of 880,000 nuclei from 18 control and 61 failing, nonischemic human hearts with pathogenic variants in DCM and ACM genes or idiopathic disease. We performed genotype-stratified analyses of the ventricular cell lineages and transcriptional states. The resultant DCM and ACM ventricular cell atlas demonstrated distinct right and left ventricular responses, highlighting genotype-associated pathways, intercellular interactions, and differential gene expression at single-cell resolution. Together, these data illuminate both shared and distinct cellular and molecular architectures of human heart failure and suggest candidate therapeutic targets.


Related Papers

No related papers found

Powered by citation graph analysis